Welcome to medications.com

Adoxa Information

What's inside Adoxa

Adoxa Active Ingredients: doxycycline monohydrate, details.
Adoxa Dosages & Strengths
Strength Format Route Strength Class
Adoxa monohydrate 150 mg tablet oral 1.0 each OTC
Adoxa monohydrate 100 mg tablet oral 1.0 each OTC
Adoxa monohydrate 75 mg tablet oral 1.0 each OTC
Adoxa monohydrate 50 mg tablet oral 1.0 each OTC

Recent Adoxa Side Effects

Posted by susanim 2 months ago
I started Adoxa for an acne cyst about 2 weeks ago and 1 week later I started having tingling fingers and toes. Is this a co...


Adoxa in the News

Diversification of the Dipsacales - Honeysuckles and Relatives - The New York Academy of Sciences
The group split early on into two major lineages – the Adoxaceae (including Viburnum, Sambucus, and Adoxa), and the Caprifoliaceae (including traditional ...
Wed Nov 07 01:12:04 -0500 2007

Bradley Pharmaceuticals 2007 Third Quarter Results - PharmaLive.com (press release)
At September 30, 2007, 100% of the ADOXA(R) 150mg tablets estimated in the wholesale and retail channel is reserved due to the generic competition that ...
Fri Nov 09 09:04:21 -0500 2007

Chuck Akre Buys Peyto Energy TR, Holltop Holdings Inc, Adds To ... - GuruFocus.com
It offers various dermatologic and podiatric products, including ADOXA and ZODERM for acne; etc. Bradley Pharmaceuticals Inc. has a market cap of $341.22 ...
Mon Aug 27 14:50:07 -0400 2007


Adoxa Chemical Information

doxycycline monohydrate - The monohydrate form of doxycycline exhibiting antimicrobial activity. Doxycycline blocks binding of aminoacyl-tRNA to the mRNA-ribosome complex, thereby inhibiting protein synthesis. In addition, this agent has exhibited inhibition of collagenase activity. (NCI)



Related Drugs
Related drugs contain similar ingredients


ADVERTISEMENT

Frequently Reported Side Effects of Adoxa

tingling fingers and toes, acne, cyst, fingers and toes
© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com